REPORTED CASES OF PERTUSSIS REMAIN HIGH AMONG ALL AGE GROUPS
Learn more about the threat of pertussis
- In 2005 there were 25,616 reported cases of pertussis12
- Pertussis is one of the only vaccine-preventable diseases that has had an increase in reported cases since 198013
- Reported cases among adolescents and adults have increased approximately 9-fold over a 16-year interval12,14,15
- It’s estimated that most cases of pertussis are not reported16,17
Ask your doctor how ADACEL vaccine can help protect you and your family from the threat of pertussis.
Back
Click below to learn more about pertussis.
What is pertussis?
Listen to the cough
The symptoms of pertussis
How is pertussis spread?
Pertussis complications
Reported cases of pertussis are on the rise
Pertussis stories
References: 1. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases—United States, 1994. Published Oct. 6, 1995, for MMWR. 1994;43(53):10. 2. CDC. Summary of notifiable diseases—United States, 1995. Published Oct. 25, 1996, for MMWR. 1995;44(53):10. 3. CDC. Summary of notifiable diseases—United States, 1996. Published Oct. 31, 1997, for MMWR. 1996;45(53):10. 4. CDC. Summary of notifiable diseases—United States, 1997. Published Nov. 20, 1998, for MMWR. 1997;46(54):10. 5. CDC. Summary of notifiable diseases—United States, 1998. Published Dec. 31, 1999, for MMWR. 1998;47(53):12. 6. CDC. Summary of notifiable diseases—United States, 1999. Published April 6, 2001, for MMWR. 1999;48(53):12. 7. CDC. Summary of notifiable diseases—United States, 2000. Published June 14, 2002, for MMWR. 2000;49(53):12. 8. CDC. Summary of notifiable diseases—United States, 2001. Published May 2, 2003, for MMWR. 2001;50(53):15. 9. CDC. Summary of notifiable diseases—United States, 2002. Published April 30, 2004, for MMWR. 2002;51(53):28. 10. CDC. Summary of notifiable diseases—United States, 2003. Published April 22, 2005, for MMWR. 2003;52(54):28. 11. CDC. Summary of notifiable diseases—United States, 2004. Published June 16, 2006, for MMWR. 2004;53(53):25. 12. CDC. Pertussis Surveillance Reports. Data on file. MKT13012. 13. CDC. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(RR-3):1-43. 14. Güris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28:1230-1237.15. CCD. Pertussis-United States, 1997-2000. MMWR. 2002;51:73-76. 16. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis. 2001;183:1353-1359. 17. US Bureau of the Census. Profiles of General Demographic Characteristics: 2000. Washington, DC: US Bureau of the Census, 2001.
SAFETY INFORMATION
Indication
Adacel vaccine is given as a single dose to people 11 through 64 years of age for active booster immunization for the prevention of tetanus (lockjaw), diphtheria, and pertussis (whooping cough).
Safety Information
Side effects to Adacel vaccine include injection site pain, redness, and swelling; headache, body ache, tiredness, and fever. Tell your doctor if you have ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Other side effects may occur. Vaccination with Adacel vaccine may not protect all people receiving the vaccine.
For more information about Adacel vaccine, talk to your health-care professional.
Last modified: 2/20/09
